Donor lymphocyte infusion for leukemia relapse after hematopoietic stem cell transplantation

Transfusion and Apheresis Science

Volumn 42, Issue 3, 2010, Pages 239-245

  Yegin, Zeynep Arzu ^a   Özkurt, Zübeyde Nur ^a   Aki, Şahika Zeynep ^a   Sucak, Gülsan Türköz ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Acute leukemia; Donor lymphocyte infusion; Hematopoietic stem cell transplantation

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DONOR LYMPHOCYTE INFUSION; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA RELAPSE; MALE; OVERALL SURVIVAL; PROBABILITY; RETROSPECTIVE STUDY; TREATMENT RESPONSE; ADOLESCENT; LEUKEMIA, MYELOID, ACUTE; LYMPHOCYTE TRANSFUSION; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; YOUNG ADULT;

ADOLESCENT; ADULT; DISEASE-FREE SURVIVAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; LYMPHOCYTE TRANSFUSION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77953023479     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2010.03.011     Document Type: Article

References (27)

1. Levine J.E., Braun T., Penza S.L., Beatty P., Cornetta K., Martino R., et al. Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem cell transplantation. J Clin Oncol 20 (2002) 405-412
2. Miekarek M., Storer B.E., Flowers M.E.D., Storb R., Sandmaier B.M., and Martin P.J. Outcomes among patients with recurrent high risk hematologic malignancies after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 13 (2007) 1160-1168
3. Pollyea D.A., Artz A.S., Stock W., Daugherty C., Godley L., Odenike O.M., et al. Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 40 (2007) 1027-1032
4. Schmid C., Labopin M., Nagler A., Bornhauser M., Finke J., Fassas A., et al. Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT acute leukemia working party. J Clin Oncol 25 (2007) 4938-4945
5. Luznik L., and Fuchs E.J. Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood and marrow transplantation. Cancer Control 9 (2002) 123-137
6. Porter D., and Levine J.E. Graft versus host disease and graft versus leukemia after donor leukocyte infusion. Semin Hematol 43 (2005) 53-61
7. Loren A.W., and Porter D.L. Donor leukocyte infusions after unrelated donor hematopoietic stem cell transplantation. Curr Opin Oncol 18 (2006) 107-114
8. Porter D.L., Levine B.L., Bunin N., Stadtmauer E.A., Luger S.M., Goldstein S., et al. A phase I trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation. Blood 107 (2006) 1325-1331
9. Kolb H.J., Schattenberg A., Goldman J.M., Hertenstein B., Jacobsen N., Arcese W., et al. Graft versus leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 86 (1995) 2041-2050
10. Porter D.L., Roth M.S., Lee S.J., McGarigle C., Ferrara J.L.M., and Antin J.H. Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation. Bone Marrow Transplant 18 (1996) 975-980
11. Collins R.H., Shpilberg O., Drobyski W.R., Porter D.L., Giralt S., Champlin R., et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 15 (1997) 433-444
12. Helg C., Starobinski M., Jeannet M., and Chapuis B. Donor lymphocyte infusion for the treatment of relapse after allogeneic hematopoietic stem cell transplantation. Leukemia Lymphoma 29 (1998) 301-313
13. Porter D.L., Connors J.M., Van Deerlin V.M.D., Duffy K.M., McGarigle C., Saidman S.L., et al. Graft versus tumor induction with donor leukocyte infusions as primary therapy for patients with malignancies. J Clin Oncol 17 (1999) 1234-1243
14. Peggs K.S., and Mackinnon S. Cellular therapy: donor lymphocyte infusion. Curr Opin Hematol 8 (2001) 349-354
15. Roush K.S., and Hillyer C.D. Donor lymphocyte infusion therapy. Transfus Med Rev 16 (2002) 161-176
16. Kobayashi K., Kami M., Murashige N., Kusumi E., Kishi Y., Hamaki T., et al. Outcomes of patients with acute leukemia who relapsed after reduced intensity stem cell transplantation from HLA identical or one antigen-mismatched related donors. Br J Haematol 129 (2005) 795-802
17. Loren A.W., and Porter D.L. Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation. Bone Marrow Transplant 41 (2008) 483-493
18. Fozza C., Szydlo R.M., Abdel-Rehim M.M., Nadal E., Goldman J.M., Apperley J.F., et al. Factors for graft versus host disease after donor lymphocyte infusions with an escalating dose regimen: lack of association with cell dose. Br J Haematol 136 (2007) 833-836
19. Sprangers B., Van Wijmeersch B., Fevery S., Waer M., and Billiau A.D. Experimental and clinical approaches for optimization of the graft versus leukemia effect. Nat Clin Pract 4 (2007) 404-414
20. Lutz C., Massenkeil G., Nagy M., Neuburger S., Tamm I., Rosen O., et al. A pilot study of prophylactic donor lymphocyte infusions to prevent relapse in adult acute lymphoblasic leukemias after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 41 (2008) 805-812
21. Rezvani A.R., and Storb R.F. Separation of graft vs tumor effects from graft vs host disease in allogeneic hematopoietic cell transplantation. J Autoimmun 30 (2008) 172-179
22. Tiribelli M., Sperotto A., Candoni A., Simeone E., Buttignol S., and Fanin R. Nilotinib and donor lymphocyte infusion in the treatment of Philadelphia positive acute lymphoblastic leukemia relapsing after allogeneic stem cell transplantation and resistant to imatinib. Leukemia Res 33 (2009) 174-177
23. Raiola A.M., Van Lint M.T., Valbonesi M., Lamparelli T., Gualandi F., Occhini D., et al. Donor lymphocyte infusions: factors predicting response and graft versus host disease after donor lymphocyte infusions: a study on 593 infusions. Bone Marrow Transplant 31 (2003) 687-693
24. Pawson R., Potter M.N., Theocharous P., Lawler M., Garg M., Yin J.A.L., et al. Treatment of relapse after allogeneic bone marrow trasnplantation with reduced intensity conditioning (FLAG ± ida) and second allogeneic stem cell transplant. Br J Haematol 115 (2001) 622-629
25. Campregher P.V., Gooley T., Scott B.L., Moravec C., Sandmaier B., Martin P.J., et al. Results of donor lymphocyte infusions for relapsed myelodysplastic syndrome after hematopoietic cell transplantation. Bone Marrow Transplant 40 (2007) 965-971
26. Miller J.S., Weisdorf D.J., Burns L.J., Slungaard A., Wagner J.E., Verneris M.R., et al. Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft versus host disease than DLI alone. Blood 110 (2007) 2761-2763
27. Marijt W.A.E., Heemskerk M.H.M., Koosterboer F.M., Goulmy E., Kester M.G.D., Van der Hoorn M.A.W.G., et al. Hematopoiesis-restricted minor histocompatibility antigens HA-1 or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proc Natl Acad Sci USA 100 (2003) 2742-2747